Aktualisierte Leitlinie „Gerinnungsselbstmanagement”

Schlüsselwörter

Antikoagulation - Gerinnung - Selbsttestung - Thromboembolie

Keywords

anticoagulation - self-testing - thromboembolism

Literatur

• 1 Anderson D R, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.  Arch Intern Med. 1993;  153 1441-1447
• 2 Ansell J, Hirsh J, Hylek E, Jacobson A. et al . Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133 160S-198
• 3 Ansell J E, Patel N, Ostrovsky D. et al . Long-term patient self-management of oral anticoagulation.  Arch Intern Med. 1995;  155 2185-2189
• 4 Bereznicki L R, Jackson S L, Peterson G M. et al . Accuracy and clinical utility of the CoaguChek® XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring.  J Clin Pathol. 2007;  60 311-314
• 5 Bernardo A, Taborski U, Wittstamm F J. Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation: Standards und Informationen. URL: http://www.asaev.de [Stand: 13.05.2008]. 
• 6 Bernardo A, Voller H. Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation A . Leitlinie „Gerinnungsselbstmanagement”.  Dtsch Med Wochenschr. 2001;  126 346-351
• 7 Beyth R J, Quinn L, Landefeld C S. A Multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial.  Ann Intern Med. 2000;  133 687-695
• 8 Biasiolo A, Rampazzo P, Furnari O. et al . Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time(R)).  Thromb Res. 2000;  97 495-498
• 9 Bodin L, Verstuyft C, Tregouet D A. et al . Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.  Blood. 2005;  106 135-140
• 10 Braun S, Watzke H, Hasenkam J M. et al . Performance evaluation of the new CoaguChek® XS system compared with the established CoaguChek® system by patients experienced in INR-self management.  Thrombosis Haemost. 2007;  97 310-314
• 11 Braun S L, Soppa C, Taborski U, Völler H. Qualitätssicherung der Patientenschulung zur Selbstkontrolle der Antikoagulation.  Z ärztl Fortbild Qual Gesundhwes. 2007;  101 194-195
• 12 Bundesministerium der Justiz . Bekanntmachung der Spitzenverbände der Krankenkassen – Fortschreibung des Hilfsmittelverzeichnisses. Produktgruppe 21 „Messgeräte für Körperzustände/-funktionen”.  Bundesanzeiger. 2002;  54 18805
• 13 Christensen T D, Johnsen S P, Hjortdal V E, Hasenkam J M. Self-management of oral anticoagulant therapy: A systematic review and meta-analysis.  Int J Cardiol. 2007;  118 54-61
• 14 Cromheecke M E, Levi M, Colly L P. et al . Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.  Lancet. 2000;  356 97-102
• 15 Dorfman D M, Goonan E M, Boutilier M K. et al . Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation.  Vasc Med. 2005;  10 23-27
• 16 Douketis J D, Lane A, Milne J. et al . Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement.  Thromb Res. 1998;  92 11-17
• 17 Fitzmaurice D A, Murray E T, Gee K M. et al . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.  J Clin Pathol. 2002;  55 845-849
• 18 Gadisseur A PA, Kaptein A A, Breukink-Engbers W GM. et al . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.  J Thromb Haemost. 2004;  2 584-591
• 19 Hasenkam J M, Kimose H H, Knudsen L. et al . Self management of oral anticoagulant therapy after heart valve replacement.  Europ J Cardiothorac Surg. 1997;  11 935-942
• 20 Heidinger K S, Bernardo A, Taborski U, Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis.  Thromb Res. 2000;  98 287-293
• 21 Heneghan C, Alonso-Coello P, Garcia-Alamino J. et al . Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.  Lancet. 2006;  367 404-411
• 22 Horstkotte D, Piper C, Wiemer M. Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease.  J Thromb Thrombolys. 1998;  5 19-24
• 23 ISO .Clinical laboratory testing and in vitro diagnostic test systems – Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy. In: ISO International Organization for Standardization. 2003: 38
• 24 Koertke H, Minami K, Bairaktaris A. et al . INR self-management following mechanical heart valve replacement.  J Thromb Thrombolys. 2000;  9 S41-S45
• 25 Koertke H, Zittermann A, Tenderich G. et al . Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.  Eur Heart J. 2007;  28 2479-84
• 26 Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?.  Ann Thorac Surg. 2001;  72 44-48
• 27 Lafata J E, Martin S A, Kaatz S, Ward R E. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.  J Gen Intern Med. 2000;  15 31-37
• 28 Leichsenring I, Plesch W, Unkrig V. et al . Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy.  Thromb Haemost. 2007;  97 856-861
• 29 Menendez-Jandula B, Souto J C, Oliver A. et al . Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial.  Ann Intern Med. 2005;  142 1-10
• 30 Müller-Beißenhirtz W, Deickert F, Lang H. et al . Selbstkontrolle der oralen Antikoagulation: Standortbestimmung.  J Lab Med. 1997;  21 558-562
• 31 Newall F, Bauman M. Point-of-care antithrombotic monitoring in children.  Thromb Res. 2006;  118 113-121
• 32 Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek(TM) S point-of-care monitor and a robust education program.  Thromb Res. 2006;  118 587-593
• 33 Piso B, Jimenz-Boj E, Krinninger B, Watzke H H. The quality of oral anticoagulation before, during and after a period of patient self-management.  Thromb Res. 2002;  106 101-104
• 34 Rost S, Fregin A, Ivaskevicius V. et al . Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.  Nature. 2004;  427 537-541
• 35 Sawicki P T. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.  JAMA. 1999;  281 145-150
• 36 Sidhu P, O’Kane H O. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients.  Ann Thorac Surg. 2001;  72 1523-1527
• 37 Siebenhofer A, Rakovac I, Kleespies C. et al . Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up.  Thromb Haemost. 2007;  97 408-416
• 38 Sunderji R, Gin K, Shalansky K. et al . A randomized trial of patient self-managed versus physician-managed oral anticoagulation.  Can J Cardiol. 2004;  20 1117-1123
• 39 Taborski U, Braun S L, Völler H. Analytical Performance of the New Coagulation Monitoring System INRatio™ for the Determination of INR Compared with the Coagulation Monitor Coaguchek® S and an Established Laboratory Method.  J Thromb Thrombolys. 2004;  18 103-107
• 40 Taborski U, Wittstamm F J, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany.  Semin Thromb Hemost. 1999;  25 103-107
• 41 van den Besselaar A M, Breddin K, Lutze G. et al . Multicenter evaluation of a new capillary blood prothrombin time monitoring system.  Blood Coagula Fibrinolysis. 1995;  6 726-732
• 42 van den Besselaar A M, Meeuwisse-Braun J. et al . A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device.  Blood Coagul Fibrinolysis. 2000;  11 559-562
• 43 van den Besselaar A M. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation.  J Thromb Thrombolys. 2001;  12 35-40
• 44 Voeller H, Dovifat C, Glatz J. et al . Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient’s knowledge of medical background and procedures.  Eur J Cardiovasc Prev Rehabil. 2004;  11 442-447
• 45 Voeller H, Dovifat C, Wegscheider K. Experience with INR self-management: patient selection and complication rates.  Z Kardiol. 2005;  94 801-7
• 46 Völler H, Glatz J, Taborski U. et al . Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study).  Z Kardiol. 2005;  94 182-186
• 47 Völler H, Taborski U, Dovifat C. et al . ProTime® self-management yielding improvement of fluency and quality of life.  Thromb Haemost. 2007;  98 889-95
• 48 Watzke H H, Forberg E, Svolba G. et al . A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.  Thromb Haemost. 2000;  83 661-665
• 49 White R H, McCurdy S A, von Marensdorff H. et al . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.  Ann Intern Med. 1989;  111 730-737